Google News – FDA (biotech/pharma) External News
Events & Conferences Articles
Google News – Clinical Trials External News
C. diff Prevention Vaccine Enters Vermont Clinical Trials - University of Vermont
Google News – CDC External News
Interim Clinical Considerations for the Use of Seasonal Influenza Vaccines in the United States - Centers for Disease Control and Prevention | CDC (.gov)
Google News – Pharmaceuticals External News
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences - Yahoo Finance
Google News – Pharmaceuticals External News
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire
Google News – Pharmaceuticals External News
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times
Google News – Pharmaceuticals External News
Enanta Pharmaceuticals to Participate in September Investor Conferences - Yahoo Finance
Google News – Pharmaceuticals External News
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference - Stock Titan
Google News – Pharmaceuticals External News
ESC 2026: Evolocumab explores new frontiers in CV disease prevention - Pharmaceutical Technology
Google News – Biopharma External News
Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference - BioSpace
Google News – Clinical Trials External News
Groundbreaking IU Clinical Trial Demonstrates First Potential Treatment That Could Prevent Millions of Annual Heart Failures and Deaths in Severe Heart Attack Patients | Newswise - Newswise
Google News – Biopharma External News
AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference - The Manila Times
Google News – Biopharma External News
AEON Biopharma to Host Investor Meetings at Lake Street Capital Markets’ 10th Annual BIG10 Conference - Quiver Quantitative
Google News – Pharmaceuticals External News
Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients - PR Newswire
Google News – Biopharma External News

